Table of Contents
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of theophylline extended-release tablets to its current portfolio.
Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.
Theophylline extended-release tablets are available in 300 mg and 450 mg strengths, both in 100 count bottles.
To find out more about theophylline extended-release tablets, visit https://www.camberpharma.com/theophylline-er
